As of 1:22:22 PM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2.5600
7.5890
125.6620
38.2640
59.5680
Cost of Revenue
171.8440
173.1220
300.7570
19.7440
104.7290
Gross Profit
-169.2840
-165.5330
-175.0950
18.5200
-45.1610
Operating Expense
2,093.3220
1,915.3380
2,061.0410
3,249.8220
7,872.4070
Operating Income
-2,262.6060
-2,080.8710
-2,236.1360
-3,231.3020
-7,917.5680
Net Non Operating Interest Income Expense
-943.1910
-308.7340
-956.8200
-508.7730
-47.5920
Other Income Expense
-2,534.8300
-1,563.7160
133.4790
-44.4870
--
Pretax Income
-5,740.6270
-3,953.3210
-3,059.4770
-3,784.5620
-7,965.1600
Net Income Common Stockholders
-5,740.6270
-3,953.3210
-3,059.4770
-3,784.5620
-7,965.1600
Diluted NI Available to Com Stockholders
-5,740.6270
-3,953.3210
-3,059.4770
-3,784.5620
-7,965.1600
Basic EPS
-0.06
-0.05
-0.05
-0.06
-0.20
Diluted EPS
-0.06
-0.05
-0.05
-0.06
-0.20
Basic Average Shares
98,061.2910
73,334.6780
66,191.6440
60,600.5480
48,829.1600
Diluted Average Shares
98,061.2910
73,334.6780
66,191.6440
60,600.5480
48,829.1600
Total Operating Income as Reported
--
-2,080.8710
-2,236.1360
-3,231.3020
-7,917.5680
Total Expenses
2,265.1660
2,088.4600
2,361.7980
3,269.5660
7,977.1360
Net Income from Continuing & Discontinued Operation
-5,740.6270
-3,953.3210
-3,059.4770
-3,784.5620
-7,965.1600
Normalized Income
-3,205.7970
-2,389.6050
-3,191.9560
-3,713.0750
-7,965.1600
Interest Income
0.0010
0.0070
0.0380
2.3580
--
Interest Expense
943.1920
308.7410
587.7250
511.1310
47.5920
Net Interest Income
-943.1910
-308.7340
-956.8200
-508.7730
-47.5920
EBIT
-4,797.4350
-3,644.5800
-2,471.7520
-3,273.4310
-7,917.5680
EBITDA
-4,788.7470
-3,610.3140
-2,429.4650
-3,233.1100
-7,883.9580
Reconciled Cost of Revenue
171.8440
173.1220
300.7570
19.7440
104.7290
Reconciled Depreciation
8.6880
34.2660
42.2870
40.3210
33.6100
Net Income from Continuing Operation Net Minority Interest
-5,740.6270
-3,953.3210
-3,059.4770
-3,784.5620
-7,965.1600
Total Unusual Items Excluding Goodwill
-2,534.8300
-1,563.7160
132.4790
-71.4870
--
Total Unusual Items
-2,534.8300
-1,563.7160
132.4790
-71.4870
--
Normalized EBITDA
-2,253.9170
-2,046.5980
-2,561.9440
-3,161.6230
-7,883.9580
12/31/2020 - 11/15/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VYYRF Voyageur Pharmaceuticals Ltd.
0.0020
0.00%
SWOBY Swedish Orphan Biovitrum AB (publ)
15.00
0.00%
BIOVF Swedish Orphan Biovitrum AB (publ)
28.62
0.00%
DUTV Digital Utilities Ventures, Inc.
0.0090
+12.20%
ROMJF Rubicon Organics Inc.
0.2730
0.00%
HEMP Hemp, Inc
0.0000
0.00%
ERBB American Green, Inc.
0.0005
-16.67%
CBDD CBD of Denver Inc.
0.0003
0.00%
CBDL CBD Life Sciences Inc.
0.0004
0.00%
TLPH Talphera, Inc.
0.6355
-5.85%